Fierce Biotech April 2, 2024
3M has finished carving out its healthcare business, formally establishing Solventum as an independent, St. Paul, Minnesota-based manufacturer of a medtech catalog that brought in $8.2 billion in 2023 sales.
The new company and its about 22,000 employees span four divisions: medical surgical tools, health IT platforms and dental solutions as well as purification and filtration hardware.
More than half of Solventum’s revenues will come from devices for advanced wound care and preventing infections in the treatment of more than 1.6 million cases annually—including negative pressure therapies, dressings and sterilizers as well as surgical drapes, electrodes and disposable wraps in addition to the long-running Littmann stethoscope brand.
“Today Solventum marks our first day as a publicly traded company and...